Peptide Antibiotics Market 2026 growing to $9.04 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Peptide Antibiotics Market Between 2026 And 2030?

The peptide antibiotics market size has witnessed strong growth in recent years. It is anticipated to increase from $5.77 billion in 2025 to $6.32 billion in 2026, with a compound annual growth rate (CAGR) of 9.6%. The historical expansion of this market can be attributed to the proliferation of antibiotic-resistant bacterial strains, higher rates of hospital-acquired infections, advancements in peptide synthesis technologies, increasing clinical research into infectious diseases, and government funding allocated for antibiotic research and development.

The peptide antibiotics market size is projected to experience substantial growth in the upcoming years. Its value is expected to reach $9.04 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.3%. This expansion during the forecast period is driven by factors such as the increasing occurrence of multi-drug resistant infections, the broadening of global healthcare infrastructure, advancements in peptide delivery systems, a rise in collaborations with CDMOs, and increased awareness and adoption of precision medicine strategies. Major trends anticipated within the forecast period include a heightened demand for multi-drug resistant (MDR) infection solutions, the wider application of peptide antibiotics in hospital-acquired infections, an increase in contract manufacturing and CDMO collaborations, the growing integration of personalized and targeted antibiotic therapies, and a strong emphasis on peptide antibiotics designed with reduced toxicity and fewer side effects.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

What Key Drivers Are Influencing The Growth Of The Peptide Antibiotics Market?

A rise in the occurrence of diverse infectious diseases is anticipated to boost the peptide antibiotics market’s expansion. These illnesses result from harmful microorganisms, including bacteria, fungi, and parasites. Key factors contributing to the surge in infectious diseases, such as rapid urbanization, climate change, and a heightened risk of new disease emergence, have consequently raised the demand for peptide antibiotics. Peptide antibiotics operate by physically disrupting cell membranes, forming the basis of their antibacterial action. For instance, in May 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that dengue cases in the America region had already exceeded seven million by April 2024, significantly more than the 4.6 million cases reported for the entirety of 2023. Consequently, the rising occurrence of infectious diseases is fueling the expansion of the peptide antibiotics market.

Which Market Segments Are Examined In The Peptide Antibiotics Market Study?

The peptide antibiotics market covered in this report is segmented –

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics

2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs

3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases

4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:

1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides

2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

Which Trends Are Influencing The Peptide Antibiotics Market?

Leading companies in the peptide antibiotics market are introducing generic versions to offer patients a more affordable alternative. These generic peptide antibiotics are economical, off-patent substitutes for brand-name peptide-based antibiotics, employed in treating various bacterial infections. For instance, in July 2023, Camber Pharmaceuticals, a US-based pharmaceutical company, expanded its product offerings with the introduction of a generic version of Daptomycin for Injection. Daptomycin for Injection is a peptide antibiotic, specifically a cyclic lipopeptide antibiotic synthesized by non-ribosomal machinery. This generic version is accessible in both 350 mg and 500 mg strengths and is prescribed for the management of complicated skin and skin structure infections (cSSSI) in adult patients and pediatric patients aged 1 to 17 years.

Who Are The Primary Competitors In The Peptide Antibiotics Market?

Major companies operating in the peptide antibiotics market are Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Basilea Pharmaceutica Ltd.

Read the full peptide antibiotics market report here:

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Peptide Antibiotics Market?

North America was the largest region in the peptide antibiotics market in 2025. The regions covered in the peptide antibiotics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Peptide Antibiotics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7780&type=smp

Browse Through More Reports Similar to the Global Peptide Antibiotics Market 2026, By The Business Research Company

Peptide Antibiotics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

Antibiotics Market Report 2026

https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795